Related Experiment Video
Updated: Feb 19, 2026

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
Published on: June 15, 2018
Distal Hereditary Motor Neuropathy Type II (Distal HMN Type II): Phenotype and Molecular Genetics
V Timmerman1, J Beuten1, J Irobi1
1Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology (VIB) and Laboratory of Neurogenetics, Born-Bunge Foundation (BBS), University of Antwerpen (UIA), Department of Biochemistry, Universiteitsplein 1, Antwerpen, BelgiumDivision of Neurology, University Hospital Antwerpen (UZA), Antwerpen, BelgiumLaboratory of Neuropathology, BornBunge Foundation (BBS), University of Antwerpen (UIA), Department of Medicine, Antwerpen, Belgium.
Abstract:
The distal hereditary motor neuropathies (distal HMN) are clinically and genetically heterogeneous and are subdivided in seven subtypes according to the mode of inheritance, age at onset and clinical evolution. We studied a multigenerational Belgian pedigree with autosomal dominant distal HMN type II. The clinical phenotype closely resembles classical Charcot-Marie-Tooth (CMT) disease with an age at onset between 15 and 25 years. Linkage studies have shown that distal HMN II is not linked to the known CMT1 and CMT2 loci. A genome-wide search was performed and significant linkage was obtained between markers D12S86 and D12S340, suggesting that a gene causing distal HMN II is located on chromosome 12q24.3. The gene encoding the human pancreatic phospholipase A2 (PLA2A), which is expressed in peripheral nerves during degeneration, is a positional candidate gene. Because no disease-specific mutations were detected in the coding region, however, PLA2A is most likely not the disease causing gene. A yeast artificial chromosome (YAC) contig map spanning the candidate region has been constructed to isolate the gene responsible for distal HMN II. Positional and functional candidate genes are currently being screened for the presence of mutations in distal HMN II patients.
Related Concept Videos
Incomplete Dominance
Pedigree Analysis
Genetic Lingo
Pleiotropy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Principles of Pharmacogenetics: Types of Genetic Variants

